NASDAQ OMX

BIMobject AB: Solar publishes the Thermrad® series digitally in BIMobject® Cloud

31.5.2017 09:17 | NASDAQ OMX

Dela

BIMobject® ("BIMobject") hosts the Thermrad® radiator series from the Denmark-based sourcing and servicing company Solar A/S ("Solar") on the platform BIMobject® Cloud. Solar is one of Northern Europe's leading sourcing and servicing companies and operates mainly in the electrical, heating and plumbing, and ventilation technology sectors. As a long-term strategic partner and shareholder in BIMobject, Solar's release of the Thermrad® radiators as digital building products paves the way for linking the value of digital products and product information with logistics. Solar's products were released on the BIMobject® Cloud in May.  

The decision to host Solar's Thermrad® radiator series on BIMobject® Cloud is a result of the cooperation between the two companies. Beginning with the Thermrad® radiators, BIMobject gives Solar the means to digitalise the company's entire product catalogue and make its components available to the more than 400 000 professional BIM users on the platform BIMobject® Cloud, no matter where these products are sourced.   

The design of the Thermrad® radiators allows for the components to be fitted close to the wall, which increases usable floor space. The Thermrad® Super 8 radiators are equipped with eight connections, which creates four different options for flexible installation either from the underside or the sides.  

As a sourcing and servicing company, Solar is the first in its capacity amongst the 975 brands currently hosted in the BIMobject® Cloud. Solar shares BIMobject's dedication to comprehensive solutions that take factors such as traceability, product flow, and installation into account from the very first phases of a building project. In this spirit, Solar and BIMobject offer BIMobject® Cloud users the option of Solar's delivery service Solar Fastbox® when selecting a BIM object from their catalogue, to have the actual product subsequently delivered with this service. Solar Fastbox® is in its origin a one-hour delivery service and a well established concept in several countries. 

"The release of Solar's products as BIM objects in our BIMobject® Cloud marks the beginning of an exciting digitalisation journey. In many ways, Solar and BIMobject work towards similar goals from different positions. Creating efficient solutions that are sustainable throughout the building process, benefitting all stakeholders, is something that's close to both our hearts. The latest developments allow us to realise a significant part of our shared vision", says Stefan Larsson, CEO and founder of BIMobject AB.

"We seek out common business opportunities in the interface between BIMobject and Solar and the first innovative step is now a reality. With this complete range, we now facilitate the opportunity to digitally design and dimension a heating solution. Solar works to increase productivity and we believe that digital construction can help create a more efficient process and eliminate waste. Therefore, we emphasise including delivery aspects already in the design phase" says Hugo Dorph, CCO at Solar A/S.

About Solar A/S
Solar Group is a leading European sourcing and services company. The company's core business centres on product sourcing, value-adding services and optimisation of their customers' businesses. Solar Group is headquartered in Denmark, generated revenue of approximately DKK 11.1 billion in 2016 and has more than 3,000 employees. Solar has been listed on Nasdaq Copenhagen since 1953, and operates under the short designation SOLAR B.

For more information, please contact: 
Louise Otto - Press contact
Tel: +46 40 - 685 29 00 
E-mail: press@bimobject.com

About BIMobject®
BIMobject® Corporation, acknowledged by investors with a Global Red Herring 100 award, and a public company on Nasdaq Stockholm First North: ticker BIM. BIMobject® is a game changer for the construction industry worldwide with its cloud based digital content management system for BIM objects. 

BIMobject as a disruptive technology corporation is at the forefront of the digitalisation of building products and materials, enabling the information to be turned into know-how earlier in the BIM processes. The BIMobject Cloud is a digital platform, where BIM professionals can reach and download BIM files from brands, from both Europe and US.  This will enable industrialisation of the construction industry and also have a huge impact on design, product selection, constructability, waste, energy, cost, quality and logistics.

Our unique solutions for Building Product Manufacturers provide development, hosting, maintenance, syndication and publication of the digital replicas of the manufacturers' products - BIM objects. The marketing and pre-sales services associated with the BIMobject Cloud are channelled and integrated, through Apps, into CAD/BIM applications to create a business-to-business communication across the globe.

Manufacturers use BIMobject® to promote and deliver their products directly into BIM processes enabling their products to be selected and generate a real improvement in sales.

Certified Adviser: Sedermera Fondkommission

https://bimobject.com 

This is an English version of an original Swedish press release communicated by BIMobject AB. In case of interpretation issues or possible differences between the different versions, the Swedish version shall apply.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: BIMobject AB via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Skriv in din e-postadress så får du ett mejl när vi har något nytt att berätta.

Senaste nyheterna från NASDAQ OMX

Nasdaq Welcomes I-AM Capital Acquisition Company (Nasdaq: IAMXU) to The Nasdaq Stock Market17.8.2017 18:50Pressmeddelande

NEW YORK, Aug. 17, 2017 (GLOBE NEWSWIRE) -- I-AM Capital Acquisition Company (Nasdaq:IAMXU), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, celebrated its initial public offering (IPO) on The Nasdaq Stock Market.  I-AM Capital's founders, Chief Executive Officer F. Jacob Cherian and Chief Financial Officer Suhel Kanuga, have been focused on investing into India over the last decade, with the distinction of completing the first listed-SPAC investment in India. "Through our keen focus and unique accomplishments in India over the last decade, we have seen our investment thesis bear fruit: India's prominence and rise on the world stage, its distinction as being one of the fastest growing major economies of the world, and its strong vibrant consumer demographics. We believe these factors are aligning well now,

Tetraphase Pharmaceuticals Announces Submission and Validation of IV Eravacycline Marketing Authorization Application by European Medicines Agency17.8.2017 14:30Pressmeddelande

WATERTOWN, Mass., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug- resistant (MDR) infections, today announced that the Marketing Authorization Application (MAA) for IV eravacycline for the treatment of complicated intra-abdominal infections (cIAI) has been submitted and was validated by the European Medicines Agency (EMA). Eravacycline is a novel, fully-synthetic fluorocycline antibiotic being developed for the treatment of serious infections, including those caused by multidrug-resistant (MDR) pathogens. The MAA filing is based on data from the phase 3 IGNITE1 clinical trial in which eravacycline was well tolerated and demonstrated statistical non-inferiority to ertapenem using the primary endpoint of clinical response at the test-of-cure (TOC) visit. "The MAA filing represents a significant milestone for Tetraphase as it is our

RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules17.8.2017 13:00Pressmeddelande

RedHill was granted the exclusive rights to promote Esomeprazole Strontium Delayed-Release (DR) Capsules to gastroenterologists in certain U.S. territories Esomeprazole Strontium DR Capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor (PPI), indicated for adults for the treatment of gastroesophageal reflux disease (GERD) and other gastrointestinal (GI) conditions   RedHill expects to initiate the U.S. promotion of Esomeprazole Strontium  DR Capsules 49.3 mg  in the coming weeks   Esomeprazole Strontium  DR Capsules 49.3 mg  will be the third commercial GI product to be promoted by RedHill in the U.S.    RedHill's GI-focused sales force currently promotes two GI s

Brand Industrial Services Announces Agreement to Acquire Venko Groep BV16.8.2017 19:40Pressmeddelande

Complementary core strengths provide broader range of services for customers KENNESAW, GA, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Brand Industrial Services, known as BrandSafway, has signed an agreement to acquire Venko Groep BV, a portfolio company of Mentha Capital. Venko will become a part of the Brand Energy & Infrastructure Services (Brand) group. "We are very pleased to announce the agreement with Venko," said Bill Hayes, President and CEO of BrandSafway. "Our combined customers in Europe will benefit from a broader range of solutions and greater depth of expertise in access, insulation and coatings. Bringing Venko's highly specialized knowledge in coatings to BrandSafway will provide the expertise we need to expand our services in the offshore market worldwide." Based in the Netherlands, with a focus on operations in the North Sea area, Venko is a leading offshore and onshore coatings maintenance provid

Abeona Therapeutics Announces Pivotal Expansion of ABO-102 Gene Therapy Clinical Trials in Sanfilippo Syndrome Type A16.8.2017 15:38Pressmeddelande

NEW YORK and CLEVELAND, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, today announced the pivotal expansion of its gene therapy clinical trials for patients with MPS IIIA in the USA, Europe and Australia. "We have completed the necessary regulatory and ethical committee approvals and site initiations in Europe and Australia in order to accelerate enrollment," stated Juan Ruiz, M.D., Ph.D., Abeona's Chief Medical Officer. "We remain very encouraged by the improvements observed in clinically relevant biomarkers post-dosing of ABO-102, including durable reductions in heparan sulfate measured in the CNS, reduction of organ disease pathology, and signals of CNS improvement or stabilization at one-year follow-up in Cohort 1 subjects, and look forward to providing a more fulsome clinical update at important clinical

CallidusCloud Wins Eight Gold Stevies® in the 2017 International Business Awards16.8.2017 14:00Pressmeddelande

CallidusCloud Lead to Money suite recognized as Best B2B New Product of the Year. LeadRocket voted Best New Product or Service of the Year in the Software - Lead Generation Solution category. DUBLIN, Calif., Aug. 16, 2017 (GLOBE NEWSWIRE) -- Callidus Software Inc. (NASDAQ:CALD), a global leader in cloud-based sales, marketing, learning, and customer experience solutions, announced today that it was named the winner of eight Gold Stevie® awards in the 2017 International Business Awards. "The eight Stevie® awards earned highlight CallidusCloud's momentum, commitment to excellence, passion for innovation and customer orientation," said Leslie Stretch, president and CEO of CallidusCloud. "They also recognize the benefits that the Lead to Money suite, honored as the Best New Product in Business-to-Business, accrues to its customers in terms of enabling faster, bigger, and more profitable sales." CallidusCloud's Go

I vårt nyhetsrum kan du läsa de senaste nyheterna, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt nyhetsrum